ClinicalTrials.Veeva

Menu

Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes

Joslin Diabetes Center logo

Joslin Diabetes Center

Status

Completed

Conditions

Celiac Disease
Type 1 Diabetes

Treatments

Dietary Supplement: Sham Challenge
Dietary Supplement: Gluten Challenge

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether the immune response causing celiac disease is related to the autoimmune response causing type-1 diabetes.

Full description

Participants meeting eligibility criteria will have blood collected before and after a three-day oral gluten challenge. This blood will be tested for biomarkers associated with islet autoimmunity and gluten-specific cellular immunity.

Enrollment

7 patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Celiac Disease by histology and serology
  • For those with Type-1 Diabetes, at least one anti-islet antibody
  • HLA-DQ2.5 genotype

Exclusion criteria

  • Not following a gluten free diet for at least 12 months
  • Known gluten exposure within the prior 2 months
  • Treatment with systemic immune modifying biological agents (adalimumab, etanercept, infliximab, certolizumab pegol) in prior 6 months
  • Treatment with systemic immunomodulatory agents in prior 30 days
  • Human immunodeficiency virus infection, untreated hepatitis B virus, or hepatitis C virus infection
  • Nut allergy
  • Hemoglobin level below normal range
  • History of angina
  • Pregnant or lactating
  • Severe symptoms to gluten challenge in the past
  • Elevation in transglutaminase-IgA or deamidated gliadin peptide IgA or IgG greater than or equal to 50% above upper limit of normal
  • Uncontrolled complications of type-1 diabetes or celiac disease which pose a risk to participation

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

7 participants in 4 patient groups

Celiac Disease Alone Gluten Challenge
Experimental group
Treatment:
Dietary Supplement: Gluten Challenge
Celiac Disease Alone Sham Challenge
Sham Comparator group
Treatment:
Dietary Supplement: Sham Challenge
Celiac Disease and T1D Gluten Challenge
Experimental group
Treatment:
Dietary Supplement: Gluten Challenge
Celiac Disease and T1D Sham Challenge
Sham Comparator group
Treatment:
Dietary Supplement: Sham Challenge

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems